Genelux Insider Trading Activity | NASDAQ:GNLX

Genelux Corp Insider Trading Activity

GNLXNASDAQ

Trade with Public

$2.96

0.114.04%

At close: Jun 18, 5:00 PM EST

$2.90

-0.065-2.19%

After Hours: Jun 18, 8:25 AM EST

Overview News Earnings Events Options Analyst RatingsInsider TradesShort Interest Stock Report

Genelux Insider Trading Activity | NASDAQ:GNLX | Benzinga

Track the latest Genelux insider trading activity. Stay informed on recent buys, sells, and market impact for Genelux stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Genelux Corp Insiders Doing?

At Genelux Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 10.19K shares worth $30.36K, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On June 4, 2026, Ralph Smalling, the company's HEAD REGULATORY sold 192 shares for 2.93 each.
On May 12, 2026, Ralph Smalling, the company's HEAD REGULATORY sold 270 shares for 2.98 each.
On March 26, 2026, Ralph Smalling, the company's HEAD REGULATORY sold 585 shares for 2.46 each.

Ownership Statistics for Genelux Corp

Shares Outstanding

44.840M

Shares Float

43525828.0%

Insider Shares Owned

1.895M

Insider Percentage Owned

4.23%

Institutional Shares Held

3.332M

Institutional Percentage Held

7.43%


Jun 04, 2026	Ralph Smalling	HEAD REGULATORY	-192.00	$2.93	-$562.56	SELL	-0.28%	67.61K	Jun 03	View
Jun 02, 2026	Thomas Zindrick J.D., Attorney-in-Fact	DIRECTOR	-10.00K	$2.98	-$29.80K	SELL	-2.07%	472.78K	Jun 01	View
May 12, 2026	Yong Yu	CHIEF SCIENTIFIC OFFICER	-605.00	$2.97	-$1.80K	SELL	-0.40%	149.71K	May 11	View
May 12, 2026	Joseph Cappello	CHIEF TECHNICAL OFFICER	-605.00	$2.97	-$1.80K	SELL	-0.39%	154.55K	May 11	View
May 12, 2026	Thomas Zindrick	PRESIDENT AND CEO	-2.80K	$2.94	-$8.23K	SELL	-0.52%	532.05K	May 11	View
May 12, 2026	Ralph Smalling	HEAD REGULATORY	-270.00	$2.98	-$804.49	SELL	-0.40%	67.80K	May 11	View
Mar 26, 2026	Ralph Smalling	HEAD REGULATORY	-585.00	$2.46	-$1.44K	SELL	-0.85%	68.07K	Mar 24 - Mar 25	View
Mar 26, 2026	Joseph Cappello	CHIEF TECHNICAL OFFICER	-906.00	$2.42	-$2.19K	SELL	-0.58%	155.15K	Mar 24	View
Mar 26, 2026	Yong Yu	SVP, CLINICAL DEVELOPMENT	-906.00	$2.42	-$2.19K	SELL	-0.62%	144.94K	Mar 24	View
Mar 26, 2026	Thomas Zindrick	PRESIDENT AND CEO	-3.58K	$2.42	-$8.67K	SELL	-0.67%	534.85K	Mar 24	View
Mar 03, 2026	Thomas Zindrick J.D., Attorney-in-Fact	DIRECTOR	-10.00K	$2.90	-$28.96K	SELL	-2.03%	482.78K	Mar 02	View
Dec 11, 2025	Yong Yu	SVP, CLINICAL DEVELOPMENT	-4.19K	$3.82	-$16.03K	SELL	-2.79%	145.84K	Aug 21 - Nov 17	View
Dec 11, 2025	Thomas Zindrick	PRESIDENT AND CEO	-17.18K	$3.86	-$66.37K	SELL	-3.09%	538.43K	Aug 21 - Nov 17	View
Dec 11, 2025	Joseph Cappello	CHIEF TECHNICAL OFFICER	-3.71K	$3.88	-$14.36K	SELL	-2.32%	156.06K	Aug 21 - Nov 17	View
Dec 09, 2025	Ralph Smalling	HEAD REGULATORY	-2.33K	$3.75	-$8.74K	SELL	-3.28%	68.66K	Aug 21 - Dec 05	View
Dec 02, 2025	Thomas Zindrick J.D., Attorney-in Fact	DIRECTOR	-10.00K	$5.00	-$50.01K	SELL	-1.99%	492.78K	Dec 01	View
May 13, 2025	Sean Ryder	GENERAL COUNSEL	-4.47K	$2.92	-$13.07K	SELL	-8.59%	47.62K	May 12	View
May 13, 2025	Thomas Zindrick	PRESIDENT AND CEO	-10.76K	$2.92	-$31.43K	SELL	-5.32%	191.45K	May 12	View
May 13, 2025	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-5.58K	$2.92	-$16.29K	SELL	-10.48%	47.64K	May 12	View
May 13, 2025	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-4.74K	$2.92	-$13.83K	SELL	-8.31%	52.27K	May 12	View
May 13, 2025	Ralph Smalling	HEAD REGULATORY	-1.26K	$2.92	-$3.68K	SELL	-3.50%	34.76K	May 12	View
Dec 30, 2024	James Tyree	—	-3.46K	$2.46	-$8.51K	SELL	-7.03%	45.79K	Dec 30	View
Dec 18, 2024	Thomas Zindrick	PRESIDENT AND CEO	-14.31K	$2.34	-$33.50K	SELL	-27.70%	37.37K	Dec 16	View
Dec 18, 2024	Lourie Zak	CHIEF FINANCIAL OFFICER	-2.10K	$2.34	-$4.92K	SELL	-4.90%	40.80K	Dec 16	View
Dec 18, 2024	Ralph Smalling	HEAD REGULATORY	-2.51K	$2.34	-$5.87K	SELL	-13.33%	16.32K	Dec 16	View
Dec 18, 2024	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-6.30K	$2.34	-$14.74K	SELL	-30.07%	14.65K	Dec 16	View
Sep 13, 2024	Aladar Szalay	—	-64.86K	$2.65	-$171.68K	SELL	-5.34%	1.15M	Sep 12 - Sep 13	View
Sep 12, 2024	James Tyree	—	-1.73K	$2.60	-$4.50K	SELL	-3.51%	47.52K	Sep 11	View
Sep 11, 2024	Aladar Szalay	—	-75.14K	$2.62	-$196.61K	SELL	-5.83%	1.21M	Sep 09 - Sep 11	View
Sep 06, 2024	Aladar Szalay	—	-42.82K	$2.09	-$89.61K	SELL	-3.21%	1.29M	Sep 03	View
Aug 30, 2024	Aladar Szalay	—	-265.55K	$2.09	-$554.41K	SELL	-16.62%	1.33M	Aug 28 - Aug 30	View
Aug 27, 2024	Aladar Szalay	—	-91.63K	$2.19	-$200.28K	SELL	-5.42%	1.60M	Aug 23 - Aug 27	View
Jul 08, 2024	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	8.37K	$2.12	-$14.52K	GRANT	334.76%	10.87K	Feb 19 - Jun 24	View
Jul 08, 2024	Sean Ryder	GENERAL COUNSEL	6.71K	$2.12	-$11.65K	GRANT	52.93%	19.39K	Feb 19 - Jun 24	View
Jul 08, 2024	Caroline Jewett	HEAD QUALITY	-206.00	$2.12	-$10.52K	SELL	-1.26%	16.17K	Feb 19 - Jun 24	View
Jun 07, 2024	James Tyree	—	6.25K	$0.00	$0.00	BUY	180.64%	9.71K	May 29	View
Jun 07, 2024	John Smither	—	6.25K	$0.00	$0.00	BUY	90.32%	13.17K	May 29	View
Jun 07, 2024	Thomas Zindrick J.D., Attorney-in-Fact	—	2.50K	$0.00	$0.00	BUY	0.54%	465.96K	May 29	View
Jun 07, 2024	Mary Mirabelli	—	8.00K	$0.00	$0.00	BUY	179.37%	12.46K	May 29	View
Jun 07, 2024	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	2.50K	$0.00	$0.00	BUY	∞	2.50K	May 29	View
Jun 07, 2024	Thomas Zindrick	PRESIDENT AND CEO	200.00K	$0.00	$0.00	BUY	1365.09%	214.65K	May 29	View
Jun 07, 2024	Ralph Smalling	HEAD REGULATORY	1.25K	$0.00	$0.00	BUY	10.36%	13.31K	May 29	View
Jun 07, 2024	Sean Ryder	GENERAL COUNSEL	10.00K	$0.00	$0.00	BUY	1748.25%	10.57K	May 29	View
Jun 07, 2024	Lourie Zak	CHIEF FINANCIAL OFFICER	31.25K	$0.00	$0.00	BUY	∞	31.25K	May 29	View
May 15, 2024	Aladar Szalay	—	-35.97K	$3.62	-$130.38K	SELL	-2.08%	1.69M	May 13 - May 15	View
May 09, 2024	Aladar Szalay	—	-19.94K	$3.78	-$75.30K	SELL	-1.14%	1.73M	May 07 - May 08	View
May 01, 2024	Aladar Szalay	—	-60.00K	$3.23	-$193.93K	SELL	-3.32%	1.75M	Apr 29 - May 01	View
Apr 24, 2024	Aladar Szalay	—	-44.40K	$3.51	-$155.65K	SELL	-2.40%	1.81M	Apr 22 - Apr 24	View
Apr 18, 2024	Aladar Szalay	—	-71.42K	$3.59	-$256.23K	SELL	-3.72%	1.85M	Apr 16 - Apr 17	View
Dec 18, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-32.53K	$13.16	-$428.18K	SELL	-100.00%	0.00	Dec 15	View
Dec 14, 2023	James Tyree	DIRECTOR	-9.00K	$13.22	-$118.97K	SELL	-72.23%	3.46K	Dec 13	View
Dec 14, 2023	John Thomas	DIRECTOR	-9.00K	$13.38	-$120.39K	SELL	-1.90%	463.46K	Dec 13	View
Dec 08, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-36.80K	$11.85	-$436.00K	SELL	-53.08%	32.53K	Dec 07	View
Nov 22, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-18.66K	$10.26	-$191.56K	SELL	-21.21%	69.33K	Nov 21	View
Nov 21, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-18.14K	$11.60	-$210.43K	SELL	-17.09%	88.00K	Nov 17 - Nov 20	View
Oct 26, 2023	Aladar Szalay	10% OWNER	-5.70K	$19.40	-$110.64K	SELL	-0.30%	1.92M	Oct 25	View
Oct 25, 2023	Aladar Szalay	10% OWNER	-49.99K	$19.97	-$998.37K	SELL	-2.53%	1.93M	Oct 23	View
Oct 25, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$12.55	-$68.15K	SELL-OPTIONS	0.00%	106.14K	Oct 24	View
Oct 16, 2023	John Thomas	DIRECTOR	-3.33K	$20.71	-$69.04K	SELL	-0.70%	472.46K	Oct 16	View
Oct 11, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$14.01	-$83.26K	SELL-OPTIONS	0.00%	106.14K	Oct 10	View
Oct 10, 2023	Aladar Szalay	10% OWNER	-14.25K	$24.93	-$355.23K	SELL	-0.72%	1.98M	Oct 05	View
Oct 04, 2023	Aladar Szalay	10% OWNER	-75.69K	$25.49	-$1.93M	SELL	-3.66%	1.99M	Oct 03	View
Sep 29, 2023	Aladar Szalay	10% OWNER	-13.55K	$24.41	-$330.67K	SELL	-0.65%	2.07M	Sep 27 - Sep 28	View
Sep 27, 2023	Aladar Szalay	10% OWNER	-42.26K	$24.38	-$1.03M	SELL	-1.99%	2.08M	Sep 25 - Sep 26	View
Sep 27, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$14.78	-$91.33K	SELL-OPTIONS	0.00%	106.14K	Sep 26	View
Sep 25, 2023	Aladar Szalay	10% OWNER	-16.59K	$27.85	-$462.00K	SELL	-0.78%	2.12M	Sep 21 - Sep 22	View
Sep 21, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$16.98	-$131.79K	SELL-OPTIONS	0.00%	106.14K	Sep 20	View
Sep 21, 2023	Sean Ryder	GENERAL COUNSEL	0.00	$18.00	-$240.00K	SELL-OPTIONS	0.00%	572.00	Sep 20	View
Sep 20, 2023	Aladar Szalay	10% OWNER	-62.46K	$24.92	-$1.56M	SELL	-3.78%	1.59M	Sep 18 - Sep 19	View
Sep 18, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$13.94	-$165.23K	SELL-OPTIONS	0.00%	106.14K	Sep 15	View
Sep 18, 2023	John Thomas	DIRECTOR	-6.67K	$23.45	-$156.31K	SELL	-1.38%	475.79K	Sep 15 - Sep 18	View
Sep 15, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-29.80K	$21.14	-$629.93K	SELL	-21.92%	106.14K	Sep 13	View
Sep 15, 2023	Aladar Szalay	10% OWNER	-44.31K	$21.80	-$965.90K	SELL	-2.65%	1.62M	Sep 13 - Sep 14	View
Sep 14, 2023	John Smither	DIRECTOR	-900.00	$20.78	-$18.70K	SELL	-11.51%	6.92K	Sep 13	View
Sep 13, 2023	Aladar Szalay	10% OWNER	-52.62K	$22.23	-$1.17M	SELL	-3.06%	1.67M	Sep 11 - Sep 12	View
Sep 11, 2023	Aladar Szalay	10% OWNER	-37.28K	$23.57	-$878.60K	SELL	-2.12%	1.72M	Sep 07 - Sep 08	View
Aug 30, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-19.80K	$24.70	-$489.06K	SELL	-12.71%	135.94K	Aug 30	View
Aug 22, 2023	Caroline Jewett	HEAD QUALITY	-515.00	$23.73	-$12.22K	SELL	-31.21%	1.14K	Aug 18	View
Aug 22, 2023	Ralph Smalling	HEAD REGULATORY	-935.00	$23.73	-$22.19K	SELL	-31.17%	2.06K	Aug 18	View
Aug 22, 2023	Doug Samuelson	CHIEF FINANCIAL OFFICER	-1.30K	$23.73	-$30.78K	SELL	-36.03%	2.30K	Aug 18	View
Aug 22, 2023	Sean Ryder	GENERAL COUNSEL	-328.00	$23.73	-$7.78K	SELL	-36.44%	572.00	Aug 18	View
Aug 22, 2023	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-3.27K	$23.73	-$77.48K	SELL	-36.28%	5.74K	Aug 18	View
Aug 22, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-3.27K	$23.73	-$77.48K	SELL	-2.05%	155.74K	Aug 18	View
Aug 22, 2023	Thomas Zindrick	PRESIDENT AND CEO	-8.35K	$23.73	-$198.12K	SELL	-36.30%	14.65K	Aug 18	View
Jan 31, 2023	Qian Zhang	ASSOCIATE VP, RESEARCH	200.00	$6.25	$1.25K	BUY	0.15%	133.53K	Jan 26	View

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.


Jun 04, 2026	Ralph Smalling	HEAD REGULATORY	-192.00	$2.93	-$562.56	SELL	-0.28%	67.61K	Jun 03	View
Jun 02, 2026	Thomas Zindrick J.D., Attorney-in-Fact	DIRECTOR	-10.00K	$2.98	-$29.80K	SELL	-2.07%	472.78K	Jun 01	View
May 12, 2026	Yong Yu	CHIEF SCIENTIFIC OFFICER	-605.00	$2.97	-$1.80K	SELL	-0.40%	149.71K	May 11	View
May 12, 2026	Joseph Cappello	CHIEF TECHNICAL OFFICER	-605.00	$2.97	-$1.80K	SELL	-0.39%	154.55K	May 11	View
May 12, 2026	Thomas Zindrick	PRESIDENT AND CEO	-2.80K	$2.94	-$8.23K	SELL	-0.52%	532.05K	May 11	View
May 12, 2026	Ralph Smalling	HEAD REGULATORY	-270.00	$2.98	-$804.49	SELL	-0.40%	67.80K	May 11	View
Mar 26, 2026	Ralph Smalling	HEAD REGULATORY	-585.00	$2.46	-$1.44K	SELL	-0.85%	68.07K	Mar 24 - Mar 25	View
Mar 26, 2026	Joseph Cappello	CHIEF TECHNICAL OFFICER	-906.00	$2.42	-$2.19K	SELL	-0.58%	155.15K	Mar 24	View
Mar 26, 2026	Yong Yu	SVP, CLINICAL DEVELOPMENT	-906.00	$2.42	-$2.19K	SELL	-0.62%	144.94K	Mar 24	View
Mar 26, 2026	Thomas Zindrick	PRESIDENT AND CEO	-3.58K	$2.42	-$8.67K	SELL	-0.67%	534.85K	Mar 24	View
Mar 03, 2026	Thomas Zindrick J.D., Attorney-in-Fact	DIRECTOR	-10.00K	$2.90	-$28.96K	SELL	-2.03%	482.78K	Mar 02	View
Dec 11, 2025	Yong Yu	SVP, CLINICAL DEVELOPMENT	-4.19K	$3.82	-$16.03K	SELL	-2.79%	145.84K	Aug 21 - Nov 17	View
Dec 11, 2025	Thomas Zindrick	PRESIDENT AND CEO	-17.18K	$3.86	-$66.37K	SELL	-3.09%	538.43K	Aug 21 - Nov 17	View
Dec 11, 2025	Joseph Cappello	CHIEF TECHNICAL OFFICER	-3.71K	$3.88	-$14.36K	SELL	-2.32%	156.06K	Aug 21 - Nov 17	View
Dec 09, 2025	Ralph Smalling	HEAD REGULATORY	-2.33K	$3.75	-$8.74K	SELL	-3.28%	68.66K	Aug 21 - Dec 05	View
Dec 02, 2025	Thomas Zindrick J.D., Attorney-in Fact	DIRECTOR	-10.00K	$5.00	-$50.01K	SELL	-1.99%	492.78K	Dec 01	View
May 13, 2025	Sean Ryder	GENERAL COUNSEL	-4.47K	$2.92	-$13.07K	SELL	-8.59%	47.62K	May 12	View
May 13, 2025	Thomas Zindrick	PRESIDENT AND CEO	-10.76K	$2.92	-$31.43K	SELL	-5.32%	191.45K	May 12	View
May 13, 2025	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-5.58K	$2.92	-$16.29K	SELL	-10.48%	47.64K	May 12	View
May 13, 2025	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-4.74K	$2.92	-$13.83K	SELL	-8.31%	52.27K	May 12	View
May 13, 2025	Ralph Smalling	HEAD REGULATORY	-1.26K	$2.92	-$3.68K	SELL	-3.50%	34.76K	May 12	View
Dec 30, 2024	James Tyree	—	-3.46K	$2.46	-$8.51K	SELL	-7.03%	45.79K	Dec 30	View
Dec 18, 2024	Thomas Zindrick	PRESIDENT AND CEO	-14.31K	$2.34	-$33.50K	SELL	-27.70%	37.37K	Dec 16	View
Dec 18, 2024	Lourie Zak	CHIEF FINANCIAL OFFICER	-2.10K	$2.34	-$4.92K	SELL	-4.90%	40.80K	Dec 16	View
Dec 18, 2024	Ralph Smalling	HEAD REGULATORY	-2.51K	$2.34	-$5.87K	SELL	-13.33%	16.32K	Dec 16	View
Dec 18, 2024	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-6.30K	$2.34	-$14.74K	SELL	-30.07%	14.65K	Dec 16	View
Sep 13, 2024	Aladar Szalay	—	-64.86K	$2.65	-$171.68K	SELL	-5.34%	1.15M	Sep 12 - Sep 13	View
Sep 12, 2024	James Tyree	—	-1.73K	$2.60	-$4.50K	SELL	-3.51%	47.52K	Sep 11	View
Sep 11, 2024	Aladar Szalay	—	-75.14K	$2.62	-$196.61K	SELL	-5.83%	1.21M	Sep 09 - Sep 11	View
Sep 06, 2024	Aladar Szalay	—	-42.82K	$2.09	-$89.61K	SELL	-3.21%	1.29M	Sep 03	View
Aug 30, 2024	Aladar Szalay	—	-265.55K	$2.09	-$554.41K	SELL	-16.62%	1.33M	Aug 28 - Aug 30	View
Aug 27, 2024	Aladar Szalay	—	-91.63K	$2.19	-$200.28K	SELL	-5.42%	1.60M	Aug 23 - Aug 27	View
Jul 08, 2024	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	8.37K	$2.12	-$14.52K	GRANT	334.76%	10.87K	Feb 19 - Jun 24	View
Jul 08, 2024	Sean Ryder	GENERAL COUNSEL	6.71K	$2.12	-$11.65K	GRANT	52.93%	19.39K	Feb 19 - Jun 24	View
Jul 08, 2024	Caroline Jewett	HEAD QUALITY	-206.00	$2.12	-$10.52K	SELL	-1.26%	16.17K	Feb 19 - Jun 24	View
Jun 07, 2024	James Tyree	—	6.25K	$0.00	$0.00	BUY	180.64%	9.71K	May 29	View
Jun 07, 2024	John Smither	—	6.25K	$0.00	$0.00	BUY	90.32%	13.17K	May 29	View
Jun 07, 2024	Thomas Zindrick J.D., Attorney-in-Fact	—	2.50K	$0.00	$0.00	BUY	0.54%	465.96K	May 29	View
Jun 07, 2024	Mary Mirabelli	—	8.00K	$0.00	$0.00	BUY	179.37%	12.46K	May 29	View
Jun 07, 2024	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	2.50K	$0.00	$0.00	BUY	∞	2.50K	May 29	View
Jun 07, 2024	Thomas Zindrick	PRESIDENT AND CEO	200.00K	$0.00	$0.00	BUY	1365.09%	214.65K	May 29	View
Jun 07, 2024	Ralph Smalling	HEAD REGULATORY	1.25K	$0.00	$0.00	BUY	10.36%	13.31K	May 29	View
Jun 07, 2024	Sean Ryder	GENERAL COUNSEL	10.00K	$0.00	$0.00	BUY	1748.25%	10.57K	May 29	View
Jun 07, 2024	Lourie Zak	CHIEF FINANCIAL OFFICER	31.25K	$0.00	$0.00	BUY	∞	31.25K	May 29	View
May 15, 2024	Aladar Szalay	—	-35.97K	$3.62	-$130.38K	SELL	-2.08%	1.69M	May 13 - May 15	View
May 09, 2024	Aladar Szalay	—	-19.94K	$3.78	-$75.30K	SELL	-1.14%	1.73M	May 07 - May 08	View
May 01, 2024	Aladar Szalay	—	-60.00K	$3.23	-$193.93K	SELL	-3.32%	1.75M	Apr 29 - May 01	View
Apr 24, 2024	Aladar Szalay	—	-44.40K	$3.51	-$155.65K	SELL	-2.40%	1.81M	Apr 22 - Apr 24	View
Apr 18, 2024	Aladar Szalay	—	-71.42K	$3.59	-$256.23K	SELL	-3.72%	1.85M	Apr 16 - Apr 17	View
Dec 18, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-32.53K	$13.16	-$428.18K	SELL	-100.00%	0.00	Dec 15	View
Dec 14, 2023	James Tyree	DIRECTOR	-9.00K	$13.22	-$118.97K	SELL	-72.23%	3.46K	Dec 13	View
Dec 14, 2023	John Thomas	DIRECTOR	-9.00K	$13.38	-$120.39K	SELL	-1.90%	463.46K	Dec 13	View
Dec 08, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-36.80K	$11.85	-$436.00K	SELL	-53.08%	32.53K	Dec 07	View
Nov 22, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-18.66K	$10.26	-$191.56K	SELL	-21.21%	69.33K	Nov 21	View
Nov 21, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-18.14K	$11.60	-$210.43K	SELL	-17.09%	88.00K	Nov 17 - Nov 20	View
Oct 26, 2023	Aladar Szalay	10% OWNER	-5.70K	$19.40	-$110.64K	SELL	-0.30%	1.92M	Oct 25	View
Oct 25, 2023	Aladar Szalay	10% OWNER	-49.99K	$19.97	-$998.37K	SELL	-2.53%	1.93M	Oct 23	View
Oct 25, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$12.55	-$68.15K	SELL-OPTIONS	0.00%	106.14K	Oct 24	View
Oct 16, 2023	John Thomas	DIRECTOR	-3.33K	$20.71	-$69.04K	SELL	-0.70%	472.46K	Oct 16	View
Oct 11, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$14.01	-$83.26K	SELL-OPTIONS	0.00%	106.14K	Oct 10	View
Oct 10, 2023	Aladar Szalay	10% OWNER	-14.25K	$24.93	-$355.23K	SELL	-0.72%	1.98M	Oct 05	View
Oct 04, 2023	Aladar Szalay	10% OWNER	-75.69K	$25.49	-$1.93M	SELL	-3.66%	1.99M	Oct 03	View
Sep 29, 2023	Aladar Szalay	10% OWNER	-13.55K	$24.41	-$330.67K	SELL	-0.65%	2.07M	Sep 27 - Sep 28	View
Sep 27, 2023	Aladar Szalay	10% OWNER	-42.26K	$24.38	-$1.03M	SELL	-1.99%	2.08M	Sep 25 - Sep 26	View
Sep 27, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$14.78	-$91.33K	SELL-OPTIONS	0.00%	106.14K	Sep 26	View
Sep 25, 2023	Aladar Szalay	10% OWNER	-16.59K	$27.85	-$462.00K	SELL	-0.78%	2.12M	Sep 21 - Sep 22	View
Sep 21, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$16.98	-$131.79K	SELL-OPTIONS	0.00%	106.14K	Sep 20	View
Sep 21, 2023	Sean Ryder	GENERAL COUNSEL	0.00	$18.00	-$240.00K	SELL-OPTIONS	0.00%	572.00	Sep 20	View
Sep 20, 2023	Aladar Szalay	10% OWNER	-62.46K	$24.92	-$1.56M	SELL	-3.78%	1.59M	Sep 18 - Sep 19	View
Sep 18, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	0.00	$13.94	-$165.23K	SELL-OPTIONS	0.00%	106.14K	Sep 15	View
Sep 18, 2023	John Thomas	DIRECTOR	-6.67K	$23.45	-$156.31K	SELL	-1.38%	475.79K	Sep 15 - Sep 18	View
Sep 15, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-29.80K	$21.14	-$629.93K	SELL	-21.92%	106.14K	Sep 13	View
Sep 15, 2023	Aladar Szalay	10% OWNER	-44.31K	$21.80	-$965.90K	SELL	-2.65%	1.62M	Sep 13 - Sep 14	View
Sep 14, 2023	John Smither	DIRECTOR	-900.00	$20.78	-$18.70K	SELL	-11.51%	6.92K	Sep 13	View
Sep 13, 2023	Aladar Szalay	10% OWNER	-52.62K	$22.23	-$1.17M	SELL	-3.06%	1.67M	Sep 11 - Sep 12	View
Sep 11, 2023	Aladar Szalay	10% OWNER	-37.28K	$23.57	-$878.60K	SELL	-2.12%	1.72M	Sep 07 - Sep 08	View
Aug 30, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-19.80K	$24.70	-$489.06K	SELL	-12.71%	135.94K	Aug 30	View
Aug 22, 2023	Caroline Jewett	HEAD QUALITY	-515.00	$23.73	-$12.22K	SELL	-31.21%	1.14K	Aug 18	View
Aug 22, 2023	Ralph Smalling	HEAD REGULATORY	-935.00	$23.73	-$22.19K	SELL	-31.17%	2.06K	Aug 18	View
Aug 22, 2023	Doug Samuelson	CHIEF FINANCIAL OFFICER	-1.30K	$23.73	-$30.78K	SELL	-36.03%	2.30K	Aug 18	View
Aug 22, 2023	Sean Ryder	GENERAL COUNSEL	-328.00	$23.73	-$7.78K	SELL	-36.44%	572.00	Aug 18	View
Aug 22, 2023	Joseph Cappello	VP, PHARMACEUTICAL DEVELOPMENT	-3.27K	$23.73	-$77.48K	SELL	-36.28%	5.74K	Aug 18	View
Aug 22, 2023	Yong Yu	VP, CLINICAL TRIAL OPERATIONS	-3.27K	$23.73	-$77.48K	SELL	-2.05%	155.74K	Aug 18	View
Aug 22, 2023	Thomas Zindrick	PRESIDENT AND CEO	-8.35K	$23.73	-$198.12K	SELL	-36.30%	14.65K	Aug 18	View
Jan 31, 2023	Qian Zhang	ASSOCIATE VP, RESEARCH	200.00	$6.25	$1.25K	BUY	0.15%	133.53K	Jan 26	View

Genelux Corp Insider Trading Activity

Genelux Insider Trading Activity | NASDAQ:GNLX | Benzinga

What is Insider Activity?

What are Genelux Corp Insiders Doing?

Notable Recent Insider Buys and Sales

Ownership Statistics for Genelux Corp

FAQ

Is insider trading legal?

What are some examples of market manipulation?

GNLX Insider Trading News

Genelux VP Sold $191K In Company Stock

10% Owner of Genelux Makes $110K Sale

Genelux Insider Trades Send a Signal

VP at Genelux Exercises Options Worth $97K

Director of Genelux Sold $69K In Stock